Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays

Molecular and Cellular Proteomics

Volumn 10, Issue 11, 2011, Pages

  Zhi, Wenbo ^a   Sharma, Ashok ^a   Purohit, Sharad ^a   Miller, Eric ^a   Bode, Bruce ^b   Anderson, Stephen W ^c   Reed, John Chip ^d   Steed, R Dennis ^d   Steed, Leigh ^a   Hopkins, Diane ^a   She, Jin Xiong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ATLANTA DIABETES ASSOCIATES   (United States)

^c Pediatric Endocrine Associates   (United States)

^d Southeastern Endocrine and Diabetes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; MYELOPEROXIDASE; PLASMA PROTEIN; SERUM AMYLOID A; SOMATOMEDIN BINDING PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA; BETAIG H3 PROTEIN; BETAIG-H3 PROTEIN; BIOLOGICAL MARKER; PEROXIDASE; SCLEROPROTEIN;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOASSAY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC REGULATION; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; RISK FACTOR; TANDEM MASS SPECTROMETRY; VALIDATION STUDY; ADOLESCENT; AGE; AGED; BLOOD; CASE CONTROL STUDY; CHILD; INFANT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; SEX DIFFERENCE;

ADIPONECTIN; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEROXIDASE; SERUM AMYLOID A PROTEIN; SEX FACTORS; TANDEM MASS SPECTROMETRY; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 80555146689     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.012203     Document Type: Article

References (49)

1. Purohit, S., and She, J. X. (2008) Risk factors and biomarkers for type 1 diabetes. Int. J. Clin. Exp. Med. 1, 98-116
2. Planas, R., Carrillo, J., Sanchez, A., de Villa, M. C., Nuñez, F., Verdaguer, J., James, R. F., Pujol-Borrell, R., and Vives-Pi, M. (2010) Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes. Clin. Exp. Immunol. 159, 23-44
3. Anderson, L. (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563, 23-60
4. Jacobs, J. M., Adkins, J. N., Qian, W. J., Liu, T., Shen, Y., Camp, D. G., 2nd, and Smith, R. D. (2005) Utilizing human blood plasma for proteomic biomarker discovery 785. J. Proteome. Res. 4, 1073-1085 (Pubitemid 41208665)
5. Wenbo Zhi, Sharad Purohit, Colleen Carey, Meiyao Wang, and in-Xiong She (2010) Proteomic technologies for the discovery of type 1 diabetes biomarkers. J. Diabetes Sci. Technol. 4
6. Sihlbom, C., Kanmert, I., Bahr, H., and Davidsson, P. (2008) Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins. J. Proteome Res. 7, 4191-4198
7. Dwivedi, R. C., Krokhin, O. V., Cortens, J. P., and Wilkins, J. A. (2009) Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. J. Proteome Res.
8. Neilson, K. A., Ali, N. A., Muralidharan, S., Mirzaei, M., Mariani, M., Assadourian, G., Lee, A., van Sluyter, S. C., and Haynes, P. A. (2011) Less label, more free: Approaches in label-free quantitative mass spectrometry. Proteomics
9. Hartwig, S., Czibere, A., Kotzka, J., Passlack, W., Haas, R., Eckel, J., and Lehr, S. (2009) Combinatorial hexapeptide ligand libraries (ProteoMinerΓ,¢): An innovative fractionation tool for differential quantitative clinical proteomics. Arch. Physiol. Biochem. 115, 155-160
10. Wilkins, M. R., Appel, R. D., Van Eyk, J. E., Chung, M. C., Görg, A., Hecker, M., Huber, L. A., Langen, H., Link, A. J., Paik, Y. K., Patterson, S. D., Pennington, S. R., Rabilloud, T., Simpson, R. J., Weiss, W., and Dunn, M. J. (2006) Guidelines for the next 10 years of proteomics. Proteomics 6, 4-8 (Pubitemid 43142925)
11. Elias, J. E., Haas, W., Faherty, B. K., and Gygi, S. P. (2005) Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2, 667-675 (Pubitemid 41223093)
12. Sekhon, J. S. (2011) Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J. Statistical Software 42, 1-52
13. Treszl, A., Szereday, L., Doria, A., King, G. L., and Orban, T. (2004) Elevated C-reactive protein levels do not correspond to autoimmunity in type 1 diabetes. Diabetes Care 27, 2769-2770 (Pubitemid 39441490)
14. Devaraj, S., Cheung, A. T., Jialal, I., Griffen, S. C., Nguyen, D., Glaser, N., and Aoki, T. (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56, 2790-2796 (Pubitemid 350044923)
15. Urieli-Shoval, S., Linke, R. P., and Matzner, Y. (2000) Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. [Miscellaneous]. Curr. Opin. Hematol. 7, 64-69 (Pubitemid 30007690)
16. Kumon, Y., Suehiro, T., Itahara, T., Ikeda, Y., and Hashimoto, K. (1994) Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. Clin. Biochem. 27, 469-473
17. Hatanaka, E., Monteagudo, P. T., Marrocos, M. S., and Campa, A. (2007) Interaction between serum amyloid A and leukocytes-A possible role in the progression of vascular complications in diabetes. Immunol. Lett. 108, 160-166 (Pubitemid 46198961)
18. Wakabayashi, I., and Masuda, H. (2006) Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin. Chim. Acta 365, 230-235 (Pubitemid 43196443)
19. Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., and Fioretto, P. (2005) Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J. Am. Soc. Nephrol. 16, S78-S82 (Pubitemid 41725090)
20. Basu, S., Larsson, A., Vessby, J., Vessby, B., and Berne, C. (2005) Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation. Diabetes Care 28, 1371-1375 (Pubitemid 40756699)
21. Clemmons, D. R. (1998) Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell. Endocrinol. 140, 19-24
22. Rosenfeld, R. G., Pham, H., Conover, C. A., Hintz, R. L., and Baxter, R. C. (1989) Structural and immunological comparison of insulin-like growth-factor binding-proteins of cerebrospinal and amniotic fluids. J. Clin. Endocrinol. Metabolism 68, 638-646 (Pubitemid 19081441)
23. Strasservogel, B., Blum, W. F., Past, R., Kessler, U., Hoeflich, A., Meiler, B., and Kiess, W. (1995) Insulin-like growth-factor (Igf)-I and Igf-Ii and Igf-binding protein-1, protein-2, and protein-3 in children and adolescents with diabetes-mellitus-Correlation with metabolic control and height attainment. J. Clin. Endocrinol. Metab. 80, 1207-1213
24. Zapf, J., Schmid, C., Guler, H. P., Waldvogel, M., Hauri, C., Futo, E., Hossenlopp, P., Binoux, M., and Froesch, E. R. (1990) Regulation of binding-proteins for insulin-like growth-factors (Igf) in humans-increased expression of Igf binding protein-2 during Igf-I treatment of healthyadults and in patients with extrapancreatic tumor hypoglycemia. J. Clin. Invest. 86, 952-961 (Pubitemid 20327388)
25. Smith, W. J., Nam, T. J., Underwood, L. E., Busby, W. H., Celnicker, A., and Clemmons, D. R. (1993) Use of insulin-like growth factor-binding protein-2 (Igfbp-2), Igfbp-3, and Igf-I for assessing growth-hormone status in short children. J. Clin. Endocrinol. Metab. 77, 1294-1299 (Pubitemid 23345485)
26. Bereket, A., Lang, C. H., Blethen, S. L., and Wilson, T. A. (1995) Insulin-like growth factor-binding protein-2 and insulin-studies in children with type-1 diabetes-mellitus and maturity-onset diabetes of the young. J. Clin. Endocrinol. Metab. 80, 3647-3652
27. Diez, J. J., and Iglesias, P. (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 148, 293-300 (Pubitemid 36410714)
28. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., and Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83 (Pubitemid 29299050)
29. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., and Matsuzawa, Y. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599 (Pubitemid 30353893)
30. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., Yamashita, S., Funahashi, T., and Matsuzawa, Y. (1999) Novel modulator for endothelial adhesion molecules-Adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476 (Pubitemid 30005109)
31. Imagawa, A., Funahashi, T., Nakamura, T., Moriwaki, M., Tanaka, S., Nishizawa, H., Sayama, K., Uno, S., Iwahashi, H., Yamagata, K., Miyagawa, J., and Matsuzawa, Y. (2002) Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 25, 1665-1666
32. Perseghin, G., Lattuada, G., Danna, M., Sereni, L. P., Maffi, P., De Cobelli, F., Battezzati, A., Secchi, A., Del Maschio, A., and Luzi, L. (2003) Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 285, E1174-E1181 (Pubitemid 37464367)
33. Schalkwijk, C. G., Chaturvedi, N., Schram, M. T., Fuller, J. H., and Stehouwer, C. D. A. (2006) Adiponectin is inversely associated with renal function in type 1 diabetic patients. J. Clin. Endocrinol. Metab. 91, 129-135 (Pubitemid 43069128)
34. Frystyk, J., Tarnow, L., Hansen, T. K., Parving, H. H., and Flyvbjerg, A. (2005) Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 48, 1911-1918 (Pubitemid 41317848)
35. Jorsal, A., Tarnow, L., Frystyk, J., Lajer, M., Flyvbjerg, A., Parving, H. H., Vionnet, N., and Rossing, P. (2008) Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 74, 649-654
36. Maahs, D. M., Ogden, L. G., Snell-Bergeon, J. K., Kinney, G. L., Wadwal, R. P., Hokanson, J. E., Dabelea, D., Kretowskil, A., Eckel, R. H., and Rewers, M. (2007) Determinants of serum adiponectin in persons with and without type 1 diabetes. Am. J. Epidemiol. 166, 731-740 (Pubitemid 47347894)
37. Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., and Paschke, R. (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 290, 1084-1089 (Pubitemid 34687474)
38. El Kochairi, I., Letovanec, I., Uffer, S., Munier, F. L., Chaubert, P., and Schorderet, D. F. (2006) Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy. Mol. Vis. 12, 461-466
39. Thapa, N., Lee, B. H., and Kim, I. S. (2007) TGFBIp/[beta]ig-h3 protein: A versatile matrix molecule induced by TGF-[beta]. Int. J. Biochem. Cell Biol. 39, 2183-2194 (Pubitemid 47484277)
40. Ha, S. W., Kim, H. J., Bae, J. S., Jeong, G. H., Chung, S. C., Kim, J. G., Park, S. H., Kim, Y. L., Kam, S., Kim, I. S., and Kim, B. W. (2004) Elevation of urinary beta ig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy. Diabetes Res. Clin. Pract. 65, 167-173 (Pubitemid 38829686)
41. Hurst, J. K., and Barrette, W. C. Jr. (1989) Leukocytic oxygen activation and microbicidal oxidative toxins. Crit. Rev. Biochem. Mol. Biol. 24, 271-328
42. Brennan, M., Gaur, A., Pahuja, A., Lusis, A. J., and Reynolds, W. F. (2001) Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 112, 97-105
43. Park, E., Jia, J., Quinn, M. R., and Schuller-Levis, G. (2002) Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin. Immunol. 102, 179-184 (Pubitemid 34171517)
44. Ramsaransing, G., Teelken, A., Prokopenko, V. M., Arutjunyan, A. V., and De Keyser, J. (2003) Low leucocyte myeloperoxidase activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 74, 953-955 (Pubitemid 36783004)
45. Sato, N., Shimizu, H., Suwa, K., Shimomura, Y., Kobayashi, I., and Mori, M. (1992) Mpo activity and generation of active O2 species in leukocytes from poorly controlled diabetic-patients. Diabetes Care 15, 1050-1052
46. Uchimura, K., Nagasaka, A., Hayashi, R., Makino, M., Nagata, M., Kakizawa, H., Kobayashi, T., Fujiwara, K., Kato, T., Iwase, K., Shinohara, R., Kato, K., and Itoh, M. (1999) Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J. Diabetes Complications 13, 264-270 (Pubitemid 30182606)
47. Wykretowicz, A., Wierusz-Wysocka, B., Wysocki, J., Szczepanik, A., and Wysocki, H. (1993) Impairment of the oxygen-dependent microbicidal mechanisms of polymorphonuclear neutrophils in patients with type-2 diabetes is not associated with increased susceptibility to infection. Diabetes Res. Clin. Pract. 19, 195-201 (Pubitemid 23176578)
48. Heilman, K., Zilmer, M., Zilmer, K., Lintrop, M., Kampus, P., Kals, J., and Tillmann, V. (2009) Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. Diabetes Res. Clin. Pract. 84, 168-173
49. Buraczynska, K., Koziol-Montewka, M., Majdan, M., Tokarz, A., and Ksiazek, A. (2004) Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Ren. Fail. 26, 633-639 (Pubitemid 39579124)